Codes ATC:
H02AB04
EMLc
Indication
Burkitt lymphoma including Burkitt leukaemia
Code ICD11:
2A85.6
INN
Methylprednisolone
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
40 mg in vial (as sodium succinate)
(EMLc)
;
125 mg in vial (as sodium succinate)
(EMLc)
Historique des statuts LME
Sexe
Tous
Âge
Enfants (1 mois - 12 ans)
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended:
- the addition of methylprednisolone 125 mg powder for injection to the EMLc;
- the deletion of methylprednisolone injection 80 mg/mL from the EMLc;
- update the description of methylprednisolone 40 mg injection (powder for injection in vial).